Welcome to our dedicated page for VEECO INSTRUMENTS SEC filings (Ticker: VECO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on VEECO INSTRUMENTS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into VEECO INSTRUMENTS's regulatory disclosures and financial reporting.
Veeco Instruments Inc. (VECO) filed a Form 144 reporting a proposed sale of 25,000 shares of common stock through Wells Fargo Clearing Services with an aggregate market value of $624,493.00. The filing lists the approximate outstanding shares as 60,161,823 and an intended sale date of 09/09/2025 on Nasdaq.
The shares to be sold were acquired in 2024 as grants: 7,138 shares on 03/13/2024, 6,787 on 03/12/2024 and 11,075 on 03/18/2024. The filer indicates no sales in the past three months and certifies no undisclosed material adverse information. This is a routine Rule 144 notice describing a proposed sale by a person whose holdings were obtained via issuer grants.
Manulife and its investment-management subsidiaries reported beneficial ownership stakes in Veeco Instruments common stock. Manulife Investment Management (US) LLC holds 3,195,268 shares, representing 5.48% of the 58,292,152 shares outstanding cited in the filing. Manulife Investment Management Limited holds 19,763 shares (about 0.03%), and through its parent-subsidiary relationship, Manulife Financial Corporation may be deemed to beneficially own these holdings.
The Schedule 13G/A clarifies voting and dispositive powers: the reporting entities state sole voting and sole dispositive power over the shares listed. The filing is a disclosure of institutional ownership crossing the 5% threshold by MIM (US) and documents the corporate and regulatory identities of the reporting persons.